JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
MXMCX
Price
$9.35
Change
+$0.06 (+0.65%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs MXMCX

Header iconJVMTX vs MXMCX Comparison
Open Charts JVMTX vs MXMCXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
Empower Ariel Mid Cap Value I
Price$9.35
Change+$0.06 (+0.65%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs MXMCX Comparison Chart
Loading...
VS
JVMTX vs. MXMCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and MXMCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. MXMCX (118M). MXMCX pays higher dividends than JVMTX: MXMCX (2.24) vs JVMTX (0.73). JVMTX was incepted earlier than MXMCX: JVMTX (11 years) vs MXMCX (31 years). JVMTX is a more actively managed with annual turnover of: 41.00 vs. MXMCX (20.00). JVMTX (0) and MXMCX (0) have matching initial minimum investment requirements. JVMTX annual gain was more profitable for investors over the last year : 19.27 vs. MXMCX (16.72). JVMTX return over 5 years is better than : 43.64 vs. MXMCX (-0.47).
JVMTXMXMCXJVMTX / MXMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years31 years-
Gain YTD11.0107.262152%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B118M19,831%
Annual Yield % from dividends0.732.2432%
Returns for 1 year19.2716.72115%
Returns for 3 years13.38-25.14-53%
Returns for 5 years43.64-0.47-9,316%
Returns for 10 years63.34-0.08-79,389%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems